NCT02269228View on ClinicalTrials.gov

Tolerability of Asasantin in Healthy Female and Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

April 30, 2000

Conditions
Healthy
Interventions
DRUG

Asasantin ER

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY